Skip to content
UniqueBaseEN
For AI ↗
Companies

cytoReason

Visit website ↗
Snapshot

As of Oct 15, 2026, UniqueBase lists 1 funding record for cytoReason; the latest is $80M (Strategic) on Jul 18, 2024.

Funding records
1
Latest round
$80M · Strategic
Total raised (reported)
—
Rows with a source link
0 of 1

Overview

cytoReason is a company headquartered in Tel Aviv, Israel.

Summary generated from the structured facts on this page.

Funding · 1

Funding

Amounts as reported; USD estimates shown only when they match

Listed 1 funding record. Latest funding: $80M (Strategic), Jul 18, 2024.

Annual trendUnit: USD
2024$80MJul 18, 2024: $80M · Strategic
DateAmountInvestorsSources
Jul 18, 2024$80M · StrategicNVIDIA, OurCrowd, 赛默飞, 辉瑞制药 No source link

Select ▸ on a row to see its source brief and links.

Valuation · 1

Valuation

Amounts as reported; USD estimates shown only when they match

Listed 1 valuation record.

Annual trendUnit: USD

No chartable valuation estimates yet.

1 listed record lack a clear date or positive USD estimate for the chart.

DateAmountInvestorsSources
Jul 18, 2024— · StrategicNVIDIA, OurCrowd, 赛默飞, 辉瑞制药 No source link

Select ▸ on a row to see its source brief and links.

Revenue

Revenue

Amounts as reported; USD estimates shown only when they match

No revenue records are listed yet.

No revenue rows to list.

Team, products & investors

Explore

Sources · 0

Sources & provenance

English text is maintained separately from the original record. Consult the original source before citing a fact.

No source links are available for this profile.